📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development of LNA Gapmer Oligonucleotide-Based Therapy for ALS/FTD Caused by the C9orf72 Repeat Expansion. (2020)

First Author: Sathyaprakash C

Attributed to: UoOxford Confidence in Concept 2013 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/978-1-0716-0771-8_14

PubMed Identifier: 32865792

Publication URI: http://europepmc.org/abstract/MED/32865792

Type: Journal Article/Review

Volume: 2176

Parent Publication: Methods in molecular biology (Clifton, N.J.)

ISSN: 1064-3745